Two leading University of Nebraska Medical Center scientists, Howard Fox, M.D., Ph.D., and Nora Sarvetnick, Ph.D., have secured a $3 million grant from the National Institutes of Health to learn how methamphetamine affects the immune system, especially when there is a virus infection.
The five-year grant from the National Institute on Drug Abuse was awarded thanks in large part to the support of the UNMC Mass Spectrometry and Proteomics Core Facility and its director Pawel Ciborowski, Ph.D.
The technology used in the core lab as well as Dr. Ciborowski’s own input into the project impressed the grant reviewers, said Dr. Fox, professor of pharmacology and experimental neuroscience.
"Our grant reviews indicated that this core lab is considered state-of-the-art,” Dr. Fox said. “The fact that Dr. Ciborowski is both a scientific and technical contributor was a significant strength in getting our grant funded."
The grant highlights the overall importance of core facilities to the UNMC research enterprise, said Dr. Sarvetnick, who is professor and director of the Nebraska Regenerative Medicine Project at UNMC.
"Our core facilities are truly essential to our research on this campus,” she said. “It was gratifying to see them recognized directly in this award."
Through world-class research and patient care, UNMC generates breakthroughs that make life better for people throughout Nebraska and beyond. Its education programs train more health professionals than any other institution in the state. Learn more at unmc.edu.
Link to photo of Howard Fox, M.D., Ph.D.
http://webmedia.unmc.edu/imgunmc/brandphotos/CRW_8325.jpg
Link to photo of Nora Sarvetnick, Ph.D.
